Total Payments
$4,853
2024 Payments
$731.61
Companies
23
Transactions
295
Medicare Patients
233
Medicare Billing
$43,269
Payment Breakdown by Category
Food & Beverage$4,853 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,853 | 295 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,439 | 100 | $0 (2024) |
| Alkermes, Inc. | $942.24 | 67 | $0 (2024) |
| ITI, Inc. | $543.52 | 26 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $301.44 | 17 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $285.51 | 12 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $210.14 | 12 | $0 (2024) |
| Lundbeck LLC | $183.06 | 8 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $135.62 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $110.38 | 7 | $0 (2024) |
| Axsome Therapeutics, Inc. | $81.89 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $731.61 | 36 | ABBVIE INC. ($143.18) |
| 2023 | $1,420 | 76 | ABBVIE INC. ($620.23) |
| 2022 | $1,445 | 101 | Alkermes, Inc. ($388.29) |
| 2021 | $1,256 | 82 | AbbVie Inc. ($301.38) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: CNS | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Insomnia | ||||||
| 05/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: PSYCHIATRY | ||||||
| 05/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Neuropsychiatry | ||||||
| 04/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Neuroscience | ||||||
| 04/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: CNS | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $57.32 | General |
| Category: Neuropsychiatry | ||||||
| 03/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.51 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ADHD | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 74 | 261 | $52,200 | $18,445 |
| 2021 | 3 | 134 | 347 | $60,140 | $22,588 |
| 2020 | 1 | 25 | 34 | $6,800 | $2,235 |
Total Patients
233
Total Services
642
Medicare Billing
$43,269
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 261 | $52,200 | $18,445 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 205 | $41,000 | $16,019 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 124 | $18,600 | $6,346 | 34.1% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 12 | 18 | $540.00 | $222.84 | 41.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 34 | $6,800 | $2,235 | 32.9% |
About Jennifer Harrison
Jennifer Harrison is a Family healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1881251189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Harrison has received a total of $4,853 in payments from pharmaceutical and medical device companies, with $731.61 received in 2024. These payments were reported across 295 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,853).
As a Medicare-enrolled provider, Harrison has provided services to 233 Medicare beneficiaries, totaling 642 services with total Medicare billing of $43,269. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Lincoln, NE
- Active Since 05/22/2019
- Last Updated 09/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881251189
Products in Payments
- VRAYLAR (Drug) $1,419
- ARISTADA (Drug) $753.39
- CAPLYTA (Drug) $615.97
- REXULTI (Drug) $391.41
- INGREZZA (Drug) $210.14
- LYBALVI (Drug) $188.85
- QELBREE (Drug) $143.82
- Qelbree (Drug) $141.69
- INVEGA SUSTENNA (Drug) $110.38
- ABILIFY MAINTENA (Drug) $93.09
- Auvelity (Drug) $81.89
- QUVIVIQ (Drug) $81.65
- Parsabiv (Drug) $80.55
- AUSTEDO (Drug) $71.86
- JORNAY PM (Drug) $48.66
- VYVANSE (Drug) $42.30
- XYWAV (Drug) $41.68
- Wakix (Drug) $40.44
- UZEDY (Drug) $39.22
- SUNOSI (Drug) $38.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lincoln
Mr. Shrenik Vyas, Fnp-C, FNP-C
Family — Payments: $7,719
Family $7,719
Mrs. Mary Glade, Aprn, APRN
Family — Payments: $5,203
Family $5,203
Alyson Ferguson, Aprn-Fnp-C, APRN-FNP-C
Family — Payments: $4,725
Family $4,725
Lori Mallory, Aprn, APRN
Family — Payments: $3,974
Family $3,974
Connie Duda, Cfnp, CFNP
Family — Payments: $3,896
Family $3,896
Samantha Nice, Aprn, APRN
Family — Payments: $3,720
Family $3,720